A regional analysis of epidermal growth factor receptor ( EGFR ) mutated lung cancer for HSE South
2017
Background
EGFR mutated lung cancer represents a subgroup with distinct clinical presentations, prognosis, and management requirements. We investigated the survival, prognostic factors, and real-world treatment of NSCLC patients with EGFR mutation in clinical practice.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
4
References
2
Citations
NaN
KQI